JPH02504312A - 高分子体の乾燥方法 - Google Patents

高分子体の乾燥方法

Info

Publication number
JPH02504312A
JPH02504312A JP50202289A JP50202289A JPH02504312A JP H02504312 A JPH02504312 A JP H02504312A JP 50202289 A JP50202289 A JP 50202289A JP 50202289 A JP50202289 A JP 50202289A JP H02504312 A JPH02504312 A JP H02504312A
Authority
JP
Japan
Prior art keywords
salts
salt
buffer
water
sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50202289A
Other languages
English (en)
Japanese (ja)
Inventor
ロサー ブルース ジョセフ
Original Assignee
クアドラント バイオリソースイズ、リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クアドラント バイオリソースイズ、リミテッド filed Critical クアドラント バイオリソースイズ、リミテッド
Publication of JPH02504312A publication Critical patent/JPH02504312A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP50202289A 1988-02-01 1989-02-01 高分子体の乾燥方法 Pending JPH02504312A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8802174 1988-02-01
GB888802174A GB8802174D0 (en) 1988-02-01 1988-02-01 Method of drying macromolecules

Publications (1)

Publication Number Publication Date
JPH02504312A true JPH02504312A (ja) 1990-12-06

Family

ID=10630853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50202289A Pending JPH02504312A (ja) 1988-02-01 1989-02-01 高分子体の乾燥方法

Country Status (8)

Country Link
EP (1) EP0353281A1 (fr)
JP (1) JPH02504312A (fr)
CN (1) CN1037518A (fr)
AU (1) AU3054889A (fr)
CS (1) CS68889A2 (fr)
ES (1) ES2018102A6 (fr)
GB (1) GB8802174D0 (fr)
WO (1) WO1989006976A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008050566A1 (fr) * 2006-09-26 2008-05-02 Arkray, Inc. Procédé de formation d'une couche réactive dans un appareil d'analyse, procédé de fabrication d'un appareil d'analyse et appareil d'analyse
WO2016009971A1 (fr) * 2014-07-14 2016-01-21 国立大学法人名古屋大学 Mesure simplifiée d'un anticorps anti-récepteur de phospholipase a2

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917470D0 (en) * 1989-07-31 1989-09-13 Quadrant Bioresources Ltd Composition and method
US5422254A (en) * 1992-02-14 1995-06-06 Oy Alko Ab Method to increase the trehalose content of organisms by transforming them with the structural genes for the short and long chains of yeast trehalose synthase
GB9211176D0 (en) * 1992-05-27 1992-07-08 Central Blood Lab Authority Assay
US5759546A (en) 1994-02-04 1998-06-02 Weinberg; Andrew D. Treatment of CD4 T-cell mediated conditions
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US5876992A (en) 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6225289B1 (en) 1998-12-10 2001-05-01 Genvec, Inc. Methods and compositions for preserving adenoviral vectors
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539450A (en) * 1966-06-30 1970-11-10 Calbiochem Stabilization of enzymes
JPS5247916A (en) * 1975-10-15 1977-04-16 Behringwerke Ag Tanning treated platelet
JPS5334518A (en) * 1976-09-09 1978-03-31 Rollei Werke Franke Heidecke Reflex camera
JPS5692822A (en) * 1979-12-03 1981-07-27 Merck & Co Inc Method of freeze drying live virus composition
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
JPS61189454A (ja) * 1985-02-18 1986-08-23 Fujisawa Pharmaceut Co Ltd 安定化された固定化抗体
EP0192320A1 (fr) * 1985-01-11 1986-08-27 Unilever Plc Préparation de réactifs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
GB1575155A (en) * 1978-04-11 1980-09-17 Merck & Co Inc Vaccine stabilizer

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539450A (en) * 1966-06-30 1970-11-10 Calbiochem Stabilization of enzymes
JPS5247916A (en) * 1975-10-15 1977-04-16 Behringwerke Ag Tanning treated platelet
JPS5334518A (en) * 1976-09-09 1978-03-31 Rollei Werke Franke Heidecke Reflex camera
JPS5692822A (en) * 1979-12-03 1981-07-27 Merck & Co Inc Method of freeze drying live virus composition
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
EP0192320A1 (fr) * 1985-01-11 1986-08-27 Unilever Plc Préparation de réactifs
JPS61189454A (ja) * 1985-02-18 1986-08-23 Fujisawa Pharmaceut Co Ltd 安定化された固定化抗体

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008050566A1 (fr) * 2006-09-26 2008-05-02 Arkray, Inc. Procédé de formation d'une couche réactive dans un appareil d'analyse, procédé de fabrication d'un appareil d'analyse et appareil d'analyse
WO2016009971A1 (fr) * 2014-07-14 2016-01-21 国立大学法人名古屋大学 Mesure simplifiée d'un anticorps anti-récepteur de phospholipase a2

Also Published As

Publication number Publication date
GB8802174D0 (en) 1988-03-02
AU3054889A (en) 1989-08-25
CS68889A2 (en) 1991-07-16
EP0353281A1 (fr) 1990-02-07
ES2018102A6 (es) 1991-03-16
WO1989006976A1 (fr) 1989-08-10
CN1037518A (zh) 1989-11-29

Similar Documents

Publication Publication Date Title
JPH02504312A (ja) 高分子体の乾燥方法
KR100771388B1 (ko) 생물학적 물질용 보존 및 저장 배지
CN109212180B (zh) 用于小分子抗原与碱性磷酸酶标记结合物的保存液及其制备方法
Mazur Principles of cryobiology
US5583200A (en) Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays
Allen et al. Oxidative hemolysis and precipitation of hemoglobin. II. Role of thiols in oxidant drug action
White The dense bodies of human platelets: inherent electron opacity of the serotonin storage particles
Mudge Studies on potassium accumulation by rabbit kidney slices: Effect of metabolic activity
US6060233A (en) Methods for the lyophilization of platelets, platelet membranes or erythrocytes
Bolingbroke et al. Calcium ions and the permeability of human erythrocytes
JPH11246593A (ja) 蛋白質および同類品の保護
CN102482641A (zh) 细胞保存方法
US4198206A (en) Method for preparing a platelet reference control
JPH03135927A (ja) 低分子量有機化合物の乾燥組成物の調整方法
JPS62118887A (ja) クレアチンキナーゼ用対照及び標準血清の製法及び該血清
Lea et al. The reaction between proteins and reducing sugars in thedry'state. Dried human blood plasma
Holland et al. Studies on the permeability of erythrocytes. III. The effect of physostigmine and acetylcholine on the permeability of dog, cat and rabbit erythrocytes to sodium and potassium
Itoh et al. Sodium and potassium distribution in isolated thymus nuclei
US9879250B2 (en) Protein-stabilizing agent and protein-stabilizing method
Anton et al. Alteration of the acetylation of sulfonamides by protein binding, sulfinpyrazone, and suramin
GROSSMAN et al. Electron microscopic localization of mitochondrial adenosine triphosphatase activity
Greig et al. Studies on permeability. IX. Replacement of potassium in erythrocytes during cholinesterase activity
US4112064A (en) Stabilized angiotensin I solutions
US4344864A (en) Method for increasing shelf-life of a serum conjugated bilirubin reference composition and composition produced thereby
Frank et al. Potassium exchange in the whole cell, cytoplasm, and nucleus of amphibian oocytes